Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
Open accessThe DOI matches its Crossref record; 224 of the 227 references it cites were found in a registry or an index.
Abstract
Apolipoprotein E (APOE) genotype is the major genetic risk factor for Alzheimer disease (AD); the 14 allele increases risk and the 12 allele is protective.In the central nervous system (CNS), apoE is produced by glial cells, is present in high-density-like lipoproteins, interacts with several receptors that are members of the low-density lipoprotein receptor (LDLR) family, and is a protein that binds to the amyloid-b (Ab) peptide.There are a variety of mechanisms by which apoE isoform may influence risk for AD.There is substantial evidence that differential effects of apoE isoform on AD risk are influenced by the ability of apoE to affect Ab aggregation and clearance in the brain.Other mechanisms are also likely to play a role in the ability of apoE to influence CNS function as well as AD, including effects on synaptic plasticity, cell signaling, lipid transport and metabolism, and neuroinflammation.ApoE receptors, including LDLRs, Apoer2, very low-density lipoprotein receptors (VLDLRs), and lipoprotein receptor-related protein 1 (LRP1) appear to influence both the CNS effects of apoE as well as Ab metabolism and toxicity.Therapeutic strategies based on apoE and apoE receptors may include influencing apoE/Ab interactions, apoE structure, apoE lipidation, LDLR receptor family member function, and signaling.Understanding the normal and disease-related biology connecting apoE, apoE receptors, and AD is likely to provide novel insights into AD pathogenesis and treatment.A lzheimer disease (AD), specifically the late- onset form of AD (LOAD), is the most common cause of dementia in individuals older than 60 years of age.Although mutations in the genes PS1, PS2, and APP cause less common forms of early-onset, autosomal dominant familial AD (FAD), these cases represent ,1% of AD.In addition to the genes that cause FAD, LOAD also has a strong genetic component.Although several susceptibility genes for AD have been reported, by far the strongest genetic risk factor for LOAD is apolipoprotein
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Those who inherit one copy of the e4 form have about three times the risk of developing Alzheimer's compared with those with two copies of the e3 form, while those who inherit two copies of the e4 form have an estimated eight-to 12-fold risk.[73][74][75]”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, LDLR and LRP1 disruption by PCSK9 may be crucial for AD progression since they are the major ApoE receptors in the brain, are involved in lipid homeostasis and intracellular signaling, and are fundamental for the regulation of neuronal structure and synaptogenesis [79].”
From The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment (2024) · cites this paper as [79]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ApoE isoforms may differentially regulate brain lipid metabolism in AD and primary tauopathies.1”
From Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist (2024) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A single copy of the ε4 allele increases disease risk by approximately four-fold while two copies of the allele increase disease risk by approximately twelvefold relative to individuals who are ε3/ε3 [1, 4, 5].”
From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the brain most cholesterol is produced de novo by astrocytes, and then transported to neurons and other cells by combining with ApoE, mainly synthesized by astrocytes, to form lipoproteins that are secreted through the ATP-binding cassette (ABC) transporters [9,10].”
From ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis (2022) · cites this paper as [9]
Experimental — accuracy not yet measured
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“…and several mechanisms have been proposed to explain this effect (Lambert et al. 1998; Walsh et al. 2002; Lacor et al. 2004; Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo et al. 2008; Shankar et al. 2008;…”
BackgroundRetractedCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 3×
“…Cite this article as Cold Spring Harb Perspect Med 2012;2:a006312 1 w w w .p er sp ec ti ve si n m ed ic in e. o rg E (APOE) genotype, with the 14 allele being an AD risk factor and the 12 allele being protective relative to the prevalent 13 allele (Corder et al. 1993; Strittmatter et al. 1993a).”
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“…to explain this effect (Lambert et al. 1998; Walsh et al. 2002; Lacor et al. 2004; Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo et al. 2008; Shankar et al. 2008; Nygaard and Strittmatter 2009; Gimbel et al.…”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“…oligomers are strong inducers of synaptic suppression, and several mechanisms have been proposed to explain this effect (Lambert et al. 1998; Walsh et al. 2002; Lacor et al. 2004; Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman…”
BackgroundStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268 · cited 4×
“…Cite this article as Cold Spring Harb Perspect Med 2012;2:a006312 1 w w w .p er sp ec ti ve si n m ed ic in e. o rg E (APOE) genotype, with the 14 allele being an AD risk factor and the 12 allele being protective relative to the prevalent 13 allele (Corder et al. 1993; Strittmatter et al. 1993a).”
BackgroundInfluentialApolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · cited 17×
“In contrast, apoAI in CNS is derived from the periphery (SorciThomas et al. 1988).”
BackgroundInfluentialShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685 · cited 1×
“…Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo et al. 2008; Shankar et al. 2008; Nygaard and Strittmatter 2009; Gimbel et al. 2010; Palop and Mucke 2010; Renner et al. 2010; Ronicke et al. 2010) (see Mucke and…”
BackgroundDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 2×
“Ab1-42 oligomers are strong inducers of synaptic suppression, and several mechanisms have been proposed to explain this effect (Lambert et al. 1998; Walsh et al. 2002; Lacor et al. 2004; Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo e…”
BackgroundHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · cited 1×
“Interestingly, single-nucleotide polymorphisms in clusterin have been shown to be a risk factor for AD (Harold et al. 2009; Lambert et al. 2009).”
BackgroundThe Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 1×
“1) (Zlokovic 2008).”
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · cited 2×
“Importantly, the 12 allele of apoE is associated with a lower risk for AD (Corder et al. 1994; Farrer et al. 1997) with an odds ratio of 12 versus 13 of 0.”
InfluentialReducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 1×
“Intriguingly, genetic deficiency of tau prevents APP/Ab-induced cognitive defects as well as excitotoxicity in mice (Roberson et al. 2007), indicating that the presence of abnormally phosphorylated tau, rather than its functional loss, is the likely reason for the severe motor defects that cause…”
BackgroundSystematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“Since then, numerous studies have confirmed that the 14 allele is the strongest genetic risk factor for both AD and CAA, or a combination of both disorders (Schmechel et al. 1993; Greenberg et al. 1995; Bertram et al. 2007).”
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 3×
“…supported by a series of recent studies that showed a broad effect of mislocalized, phosphorylated tau on the spinodendritic targeting of Fyn (Ittner et al. 2010) and of the scaffolding protein JIP1 (Ittner et al. 2010), as well as on the disruption of glutamate receptor trafficking and…”
BackgroundCNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711 · cited 1×
“In vitro studies have shown that cholesterol released from apoE-containing lipoprotein particles is used to support synaptogenesis (Mauch et al. 2001) and the maintenance of synaptic connections (Pfrieger 2003).”
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 1×
“Ca2þ influx through synaptic NMDA receptors stimulates CREB phosphorylation and promotes neuronal survival, whereas excitotoxic stimulation of extrasynaptic NMDA receptors shuts off CREB phosphorylation and promotes neuronal death (Hardingham et al. 2002).”
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · cited 10×
“Strong evidence suggests a major mechanism by which apoE influences AD and cerebral amyloid angiopathy (CAA) is via its effects on Ab metabolism (Kim et al. 2009a; Castellano et al. 2011).”
InfluentialSelf-citationPalop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · cited 2×
“…providing a novel mechanism by which accelerated spine loss, increased tau phosphorylation (Kocherhans et al. 2010), loss of network homeostasis (Palop et al. 2007; Palop and Mucke 2010), and earlier disease onset through loss of neuroprotective compensatory bandwidth (Korwek et al. 2009) can…”
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · cited 2×
“…mechanism by which accelerated spine loss, increased tau phosphorylation (Kocherhans et al. 2010), loss of network homeostasis (Palop et al. 2007; Palop and Mucke 2010), and earlier disease onset through loss of neuroprotective compensatory bandwidth (Korwek et al. 2009) can be readily explained.”
BackgroundShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 4×
“Synaptic suppression by the oligomers correlates with reduced NMDA receptor activity (Snyder et al. 2005; Shankar et al. 2007), which is caused by NMDA receptor dephosphorylation and accelerated endocytosis (Snyder et al. 2005).”
BackgroundInfluentialRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 6×
“Ab oligomers interfere with NMDAR tyrosine phosphorylation by activating tyrosine phosphatases (Snyder et al. 2005).”
BackgroundInfluentialSchmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525 · cited 2×
“Since then, numerous studies have confirmed that the 14 allele is the strongest genetic risk factor for both AD and CAA, or a combination of both disorders (Schmechel et al. 1993; Greenberg et al. 1995; Bertram et al. 2007).”
BackgroundShibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 1×
“Recombinant RAP and LRP1 antibody also reduce Ab efflux from mouse brain (Shibata et al. 2000).”
BackgroundSelf-citationStrittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294 · cited 1×
“3), which under certain conditions may be toxic (Billings et al. 2005).”
BackgroundTrommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261 · cited 4×
“…phosphorylation disrupt neuronal vesicle transport by compromising microtubule stability (Mudher et al. 2004), and consequently lead to variable degrees of neuronal dysfunction and premature death of signaling defective mutant mice (Sheldon et al. 1997; Trommsdorff et al. 1999; Brich et al. 2003).”
InfluentialSelf-citationHuman ApoE isoforms differentially regulate brain amyloid-β peptide clearance
Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,242 · cited 3×
“Strong evidence suggests a major mechanism by which apoE influences AD and cerebral amyloid angiopathy (CAA) is via its effects on Ab metabolism (Kim et al. 2009a; Castellano et al. 2011).”
BackgroundSelf-citationApolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168 · cited 5×
“2010), as well as learning and memory (reviewed in Herz and Beffert 2000; Herz and Chen 2006; Bu 2009; Herz 2009).”
InfluentialSelf-citationThe neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · cited 5×
“Supporting a role for sorLA in AD pathogenesis, a genetic study showed that inherited variants in the SORL1 gene (which encodes sorLA) are associated with LOAD (Rogaeva et al. 2007).”
InfluentialNamba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91092-f · Cited by 1,157 · cited 2×
“In regard to the connection between apoE and AD, apoE was found to colocalize with amyloid plaques in the early 1990s (Namba et al. 1991; Wisniewski and Frangione 1992).”
BackgroundHoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118 · cited 2×
“2010), as well as on the disruption of glutamate receptor trafficking and recycling (Hoover et al. 2010).”
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107 · cited 2×
“First, whereas LRP1 is highly expressed in neurons and to a lesser degree in glia, LDLR is more prominently expressed in glia than neurons (Rebeck et al. 1993; Rapp et al. 2006).”
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075 · cited 1×
“Conversely, if APP is retained at the cell surface, it has a greater availability for the cell-surface-localized a-secretase and is cleaved to sAPPa and a minimally toxic peptide p3 (see Haass et al. 2011 for details).”
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954 · cited 1×
“…strong inducers of synaptic suppression, and several mechanisms have been proposed to explain this effect (Lambert et al. 1998; Walsh et al. 2002; Lacor et al. 2004; Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo…”
BackgroundHoltzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · cited 3×
“In addition, the anatomical pattern of Ab deposition differs in the absence of apoE (Holtzman et al. 2000a; Irizarry et al. 2000).”
BackgroundSelf-citationHiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., & Herz, J. (1999) · Neuron · doi:10.1016/s0896-6273(00)80861-2 · Cited by 916 · cited 5×
“Tau hyperphosphorylation in Reelin signaling defective animals on a mixed strain background is highly variable (Hiesberger et al. 1999) and strongly dependent on the background strains.”
InfluentialSelf-citationApoE Promotes the Proteolytic Degradation of Aβ
Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876 · cited 1×
“Data from in vitro studies support the idea that apoE facilitates the binding and internalization of soluble Ab by cells or its clearance via enzymes such as neprilysn (Beffert et al. 1998; Yang et al. 1999; Cole and Ard 2000; Koistinaho et al. 2004; Jiang et al. 2008).”
BackgroundSelf-citationMa, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871 · cited 1×
“E2) (Ma et al. 1994; Wisniewski et al. 1994; Castano et al. 1995), whereas others show that apoE inhibits fibrillization (Evans et al. 1994; Wood et al. 1996).”
BackgroundLack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830 · cited 1×
“…mice were crossed with apoE2/2 mice, there was less Ab deposition and a virtual abolishment of true amyloid plaques, plaque-associated neuritic dystrophy, CAA, and CAA-associated microhemorrhage in the absence of apoE (Bales et al. 1997; Bales et al. 1999; Holtzman et al. 2000b; Fryer et al. 2003).”
BackgroundAPOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830 · cited 2×
“Further, apoE2-positive individuals rarely develop fibrillar Ab as defined by a positive amyloidimaging scan (Morris et al. 2010).”
BackgroundSelf-citationLRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828
Reelin Is a Ligand for Lipoprotein Receptors
D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., & Curran, T. (1999) · Neuron · doi:10.1016/s0896-6273(00)80860-0 · Cited by 808 · cited 2×
“Both receptors bind the large homo-oligomeric signaling protein Reelin with high affinity (D’Arcangelo et al. 1999; Hiesberger et al. 1999), resulting in their clustering at the plasma membrane (Strasser et al.”
Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid
Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802 · cited 3×
“In regard to the connection between apoE and AD, apoE was found to colocalize with amyloid plaques in the early 1990s (Namba et al. 1991; Wisniewski and Frangione 1992).”
Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro
Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., & Pitas, R. E. (1994) · Science · doi:10.1126/science.8171342 · Cited by 795 · cited 2×
“Although there is some in vitro (Nathan et al. 1994; Holtzman et al. 1995) and in vivo (Masliah et al.”
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785 · cited 1×
“Cognitively normal apoE4-positive middle-aged and elderly individuals are much more likely to have brain amyloid (Reiman et al. 2009; Morris et al. 2010) and low CSF Ab42 (Sunderland et al. 2004; Morris et al. 2010) than apoE4-negative individuals.”
BackgroundSrc kinases: a hub for NMDA receptor regulation
Salter, M. W., & Kalia, L. V. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1368 · Cited by 776
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · cited 2×
“Interestingly, a recent study shows that Ab binding to apoE4 redirects its clearance from LRP1 to VLDLR, which internalizes Ab-apoE4 complexes at the BBB more slowly than LRP1 (Deane et al. 2008).”
BackgroundSelf-citationTissir, F., & Goffinet, A. M. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1113 · Cited by 751
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · cited 1×
“…Lacor et al. 2004; Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo et al. 2008; Shankar et al. 2008; Nygaard and Strittmatter 2009; Gimbel et al. 2010; Palop and Mucke 2010; Renner et al. 2010; Ronicke et al.…”
BackgroundAstrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693 · cited 3×
“2) (Pitas et al. 1987; Grehan et al. 2001).”
Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670 · cited 3×
“E2) (Bell et al. 2007; Ito et al. 2007; Deane et al. 2008).”
BackgroundSelf-citationLillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., & Strickland, D. K. (2008) · Physiological Reviews · doi:10.1152/physrev.00033.2007 · Cited by 669 · cited 2×
“…of signaling proteins and modules, and thereby modulate their intrinsic activity (Boucher et al. 2002; Loukinova et al. 2002; Huang et al. 2003; Lillis et al. 2008; Zurhove et al. 2008), including that of the N-methyl-D-aspartate (NMDA) receptor (May et al. 2004; Beffert et al. 2005; Hoe et…”
BackgroundCirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660
Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A. F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503689102 · Cited by 655 · cited 2×
“Importantly, a deletion of the Sorla gene in mice increases concentration of Ab in the brain (Andersen et al. 2005).”
Roberson, E. D., Halabisky, B., Yoo, J. W., Yao, J., Chin, J., Yan, F., Wu, T., Hamto, P., Devidze, N., Yu, G.-Q., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4152-10.2011 · Cited by 654 · cited 1×
“Intriguingly, the tau-induced synaptic defects are prevented or reversed by reducing the tau levels (Roberson et al. 2011; Sydow et al. 2011).”
BackgroundScrambler and yotari disrupt the disabled gene and produce a reeler -like phenotype in mice
Sheldon, M., Rice, D. S., D'Arcangelo, G., Yoneshima, H., Nakajima, K., Mikoshiba, K., Howell, B. W., Cooper, J. A., Goldowitz, D., & Curran, T. (1997) · Nature · doi:10.1038/39601 · Cited by 638 · cited 2×
“…phosphorylation disrupt neuronal vesicle transport by compromising microtubule stability (Mudher et al. 2004), and consequently lead to variable degrees of neuronal dysfunction and premature death of signaling defective mutant mice (Sheldon et al. 1997; Trommsdorff et al. 1999; Brich et al. 2003).”
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning
Weeber, E. J., Beffert, U., Jones, C., Christian, J. M., Förster, E., Sweatt, J. D., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205147200 · Cited by 623 · cited 12×
“In addition to effects on the apoE/Ab pathway, apoE receptors such as Apoer2 and Vldlr play important roles in synaptic plasticity, tau phosphorylation, and neuroprotection.”
InfluentialSelf-citationTownsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619 · cited 1×
“…have been proposed to explain this effect (Lambert et al. 1998; Walsh et al. 2002; Lacor et al. 2004; Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo et al. 2008; Shankar et al. 2008; Nygaard and…”
BackgroundApolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · cited 2×
“Data from in vitro studies support the idea that apoE facilitates the binding and internalization of soluble Ab by cells or its clearance via enzymes such as neprilysn (Beffert et al. 1998; Yang et al. 1999; Cole and Ard 2000; Koistinaho et al. 2004; Jiang et al. 2008).”
BackgroundThe Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550
Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy
Greenberg, S. M., William Rebeck, G., Vonsattel, J. P. G., Gomez‐Isla, T., & Hyman, B. T. (1995) · Annals of Neurology · doi:10.1002/ana.410380219 · Cited by 541 · cited 1×
“Since then, numerous studies have confirmed that the 14 allele is the strongest genetic risk factor for both AD and CAA, or a combination of both disorders (Schmechel et al. 1993; Greenberg et al. 1995; Bertram et al. 2007).”
BackgroundIsoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Xu, Q., Bernardo, A., Walker, D., Kanegawa, T., Mahley, R. W., & Huang, Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5476-05.2006 · Cited by 524 · cited 1×
“Under certain conditions, such as after excitotoxic injury, some neurons appear to be able to synthesize apoE (Xu et al. 1999; Xu et al. 2006).”
BackgroundReelin, lipoprotein receptors and synaptic plasticity
Herz, J., & Chen, Y. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2009 · Cited by 524 · cited 4×
“2007), suggesting that Ab can reduce Reelin expression in a subset of entorhinal pyramidal neurons, thereby adding further support to a role of diminished Reelin signaling in AD progression (Herz and Chen 2006).”
InfluentialSelf-citationHerz, J., Clouthier, D. E., & Hammer, R. E. (1992) · Cell · doi:10.1016/0092-8674(92)90511-a · Cited by 497 · cited 1×
“The very nature of their essential functions during the development of the embryo in general (Herz et al. 1992; Johnson et al. 2005; Dietrich et al. 2010; Karner et al. 2010), and the brain, in particular (Willnow et al. 1996; Trommsdorff 6 Cite this article as Cold Spring Harb Perspect Med…”
BackgroundSelf-citationBeffert, U., Weeber, E. J., Durudas, A., Qiu, S., Masiulis, I., Sweatt, J. D., Li, W.-P., Adelmann, G., Frotscher, M., Hammer, R. E., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.07.007 · Cited by 497 · cited 10×
“…al. 2004), n-cofilin-mediated actin reorganization (Chai et al. 2009; Frotscher 2010), and tyrosine phosphorylation of NMDA Cite this article as Cold Spring Harb Perspect Med 2012;2:a006312 7 w w w .p er sp ec ti ve si n m ed ic in e. o rg receptor subunits (Beffert et al. 2005; Chen et al. 2005).”
BackgroundInfluentialSelf-citationBales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., Fishman, C. E., DeLong, C. A., Piccardo, P., Petegnief, V., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15233 · Cited by 486 · cited 2×
“Early studies with APP-transgenic (Tg) mice that develop Ab deposition in the brain (PDAPP and Tg2576 models) showed that when these mice were crossed with apoE mice, there was less Ab deposition and a virtual abolishment of true amyloid plaques, plaque-associated neuritic dystrophy, CAA, and CAA-associated microhemor…”
BackgroundDefective forebrain development in mice lacking gp330/megalin.
Willnow, T. E., Hilpert, J., Armstrong, S. A., Rohlmann, A., Hammer, R. E., Burns, D. K., & Herz, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8460 · Cited by 483 · cited 1×
“…of the embryo in general (Herz et al. 1992; Johnson et al. 2005; Dietrich et al. 2010; Karner et al. 2010), and the brain, in particular (Willnow et al. 1996; Trommsdorff 6 Cite this article as Cold Spring Harb Perspect Med 2012;2:a006312 w w w .p er sp ec ti ve si n m ed ic in e. o…”
Self-citationA role for Cajal–Retzius cells and reelin in the development of hippocampal connections
Del Río, J. A., Heimrich, B., Borrell, V., Förster, E., Drakew, A., Alcántara, S., Nakajima, K., Miyata, T., Ogawa, M., Mikoshiba, K., et al. (1997) · Nature · doi:10.1038/385070a0 · Cited by 472 · cited 2×
“…is essential for normal brain development by regulating a pathway that controls the migration and positioning of the neuronal cell bodies in their appropriate cortical layers of the neocortex and the cerebellum (Tissir and Goffinet 2003), as well as neuronal connectivity (Del Rio et al. 1997).”
BackgroundDeleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.029 · Cited by 468 · cited 1×
“…al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo et al. 2008; Shankar et al. 2008; Nygaard and Strittmatter 2009; Gimbel et al. 2010; Palop and Mucke 2010; Renner et al. 2010; Ronicke et al. 2010) (see Mucke and Selkoe 2011).”
BackgroundApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition
DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., Harmony, J. A. K., Aronow, B. J., Bales, K. R., Paul, S. M., et al. (2004) · Neuron · doi:10.1016/s0896-6273(03)00850-x · Cited by 459 · cited 2×
“The mechanism for this is unclear, although animal model data have shown that clusterin strongly influences Ab aggregation and toxicity in vivo (DeMattos et al. 2002; DeMattos et al. 2004).”
Self-citationCholesterol homeostasis and function in neurons of the central nervous system
Pfrieger, F. W. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3018-7 · Cited by 453 · cited 1×
“In vitro studies have shown that cholesterol released from apoE-containing lipoprotein particles is used to support synaptogenesis (Mauch et al. 2001) and the maintenance of synaptic connections (Pfrieger 2003).”
BackgroundTrommsdorff, M., Borg, J.-P., Margolis, B., & Herz, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33556 · Cited by 453 · cited 5×
“The simultaneous interaction of the adapter protein Disabled 1 (Dab1) with NPxY motifs in their intracellular domains (ICDs) (Trommsdorff et al. 1998; Stolt et al. 2005) results in the progressive recruitment and transphosphorylation of Src family tyrosine kinases (SFKs) (Howell et al. 1997; Arnaud…”
InfluentialSelf-citationGotthardt, M., Trommsdorff, M., Nevitt, M. F., Shelton, J., Richardson, J. A., Stockinger, W., Nimpf, J., & Herz, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000955200 · Cited by 450 · cited 2×
“…harbor a variety of short conserved sequence stretches, such as the tetra-amino acid NPxY motif, which serve as docking sites for a wide array of cytoplasmic adaptor and scaffolding proteins (Trommsdorff et al. 1998; Gotthardt et al. 2000; Beffert et al. 2005; Hoe et al. 2006a; Hoe et al. 2006b).”
BackgroundSelf-citationThe actin cytoskeleton: integrating form and function at the synapse
Dillon, C., & Goda, Y. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135757 · Cited by 447 · cited 1×
“The dynamic remodeling of synaptic connections requires constant reorganization of actin filaments (Dillon and Goda 2005).”
Kowal, R. C., Herz, J., Weisgraber, K. H., Mahley, R. W., Brown, M. S., & Goldstein, J. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)87014-4 · Cited by 445 · cited 2×
“…si n m ed ic in e. o rg particles secreted by astrocytes have higher affinity for LDLR than LRP1 (Fryer et al. 2005a), whereas recombinant apoE (Narita et al. 2002), apoE-enriched lipoprotein particles (Kowal et al. 1990), and CSF-isolated HDL particles (Fagan et al. 1996) bind more avidly to LRP1.”
Self-citationAcceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
(1994) · PubMed Central · Cited by 441
Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide
Hu, X., Crick, S. L., Bu, G., Frieden, C., Pappu, R. V., & Lee, J.-M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911281106 · Cited by 426 · cited 1×
“Depending on the concentrations and cellular conditions, some Ab molecules might aggregate within the lysosomes as intracellular Ab, which could eventually serve to seed amyloid plaques (Hu et al. 2009).”
BackgroundSelf-citationMemory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., & Strittmatter, S. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0395-10.2010 · Cited by 418 · cited 2×
“Ab1-42 oligomers are strong inducers of synaptic suppression, and several mechanisms have been proposed to explain this effect (Lambert et al. 1998; Walsh et al. 2002; Lacor et al. 2004; Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo e…”
Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis
Mandrekar, S., Jiang, Q., Lee, C. Y. D., Koenigsknecht-Talboo, J., Holtzman, D. M., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5572-08.2009 · Cited by 415 · cited 1×
“In contrast, receptormediated internalization of Ab by astrocytes (Koistinaho et al. 2004) and microglia (Mandrekar et al. 2009) is likely to represent a more functional pathway to clear and eventually degrade Ab.”
BackgroundSelf-citationOverexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease
Wahrle, S. E., Jiang, H., Parsadanian, M., Kim, J., Li, A., Knoten, A., Jain, S., Hirsch-Reinshagen, V., Wellington, C. L., Bales, K. R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33622 · Cited by 407 · cited 1×
“…APP Tg mice are crossed onto an Abca12/2 background, this decreases apoE lipidation and increases amyloid deposition (Hirsch-Reinshagen et al. 2005; Koldamova et al. 2005a; Wahrle et al. 2005), whereas increasing ABCA1 increases apoE lipidation and decreases amyloid deposition (Wahrle et al. 2008).”
BackgroundSelf-citationSanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., & Roses, A. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117407 · Cited by 404 · cited 1×
“Lipid-free and lipidated (physiological) forms of apoE can interact with Ab in vitro (Strittmatter et al. 1993b; LaDu et al. 1994; Sanan et al. 1994; Aleshkov et al. 1997; Yang et al. 1997; Tokuda et al. 2000).”
BackgroundNeurodegeneration in the Central Nervous System of apoE-Deficient Mice
Masliah, E., Mallory, M., Ge, N., Alford, M., Veinbergs, I., & Roses, A. D. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1088 · Cited by 402 · cited 2×
“1995) and in vivo (Masliah et al. 1995; Poirier 2003) data suggesting that apoE can play a role in neuronal sprouting after injury, whether apoE plays a major role in supporting synaptogenesis and maintenance of synaptic connections in vivo in the uninjured brain has not yet been proven.”
Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T., & Strickland, D. K. (1995) · Cell · doi:10.1016/0092-8674(95)90320-8 · Cited by 401 · cited 1×
“LRP1 interacts with APP extracellularly by binding to the Kunitz-type protease inhibitor (KPI) domain that is present in the longer forms of APP (APP751 and APP770) (Kounnas et al. 1995).”
BackgroundDeficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain
Hirsch-Reinshagen, V., Zhou, S., Burgess, B. L., Bernier, L., McIsaac, S. A., Chan, J. Y., Tansley, G. H., Cohn, J. S., Hayden, M. R., & Wellington, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407962200 · Cited by 385 · cited 2×
“There is some evidence that apoE isoforms may differ in their function in regard to cholesterol transport and efflux (Michikawa et al. 2000; Gong et al. 2002; Rapp et al. 2006), although not all studies show this (Hirsch-Reinshagen et al. 2004).”
Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway
Niu, S., Renfro, A., Quattrocchi, C. C., Sheldon, M., & D'Arcangelo, G. (2004) · Neuron · doi:10.1016/s0896-6273(03)00819-5 · Cited by 375 · cited 4×
“…and observations point toward a role for Reelin and ApoE receptors in the formation of neuronal connections (Del Rio et al. 1997; Borrell et al. 2007) and the generation of dendritic complexity (Trommsdorff et al. 1999; Costa et al. 2001; Niu et al. 2004; Matsuki et al. 2008; Hoe et al. 2009).”
InfluentialClearance of amyloid-β by circulating lipoprotein receptors
Sagare, A., Deane, R., Bell, R. D., Johnson, B., Hamm, K., Pendu, R., Marky, A., Lenting, P. J., Wu, Z., Zarcone, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1635 · Cited by 373 · cited 8×
“There are two major pathways by which Ab is cleared from the brain: (1) receptor-mediated clearance by cells in brain parenchyma (microglia, astrocytes, neurons), along the interstitial fluid (ISF) drainage pathway or through the BBB and (2) through endopeptidase-mediated proteolytic degradation (see Saido and Leissri…”
BackgroundInfluentialChen, Y., Durakoglugil, M. S., Xian, X., & Herz, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914984107 · Cited by 368 · cited 10×
“The strong association of ApoE4 with late-onset AD raised the possibility that ApoE is mediating its powerful effect on the average age of disease onset at least in part through the receptors to which it binds.”
InfluentialSelf-citationProteolytic Degradation of Amyloid -Protein
Saido, T., & Leissring, M. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006379 · Cited by 368
Liu, Q., Zerbinatti, C. V., Zhang, J., Hoe, H.-S., Wang, B., Cole, S. L., Herz, J., Muglia, L., & Bu, G. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.008 · Cited by 364
Self-citationShu, T., Ayala, R., Nguyen, M.-D., Xie, Z., Gleeson, J. G., & Tsai, L.-H. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.030 · Cited by 361 · cited 2×
“…signaling events, which are not limited to the control of GSK3b activity but also involve the regulation of Lis1-dependent nuclear translocation (Shu et al. 2004), n-cofilin-mediated actin reorganization (Chai et al. 2009; Frotscher 2010), and tyrosine phosphorylation of NMDA Cite this…”
DeMattos, R. B., O'dell, M. A., Parsadanian, M., Taylor, J. W., Harmony, J. A. K., Bales, K. R., Paul, S. M., Aronow, B. J., & Holtzman, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162228299 · Cited by 359 · cited 1×
“The mechanism for this is unclear, although animal model data have shown that clusterin strongly influences Ab aggregation and toxicity in vivo (DeMattos et al. 2002; DeMattos et al. 2004).”
Self-citationReelin Activates Src Family Tyrosine Kinases in Neurons
Bock, H. H., & Herz, J. (2003) · Current Biology · doi:10.1016/s0960-9822(02)01403-3 · Cited by 355 · cited 2×
“2005) results in the progressive recruitment and transphosphorylation of Src family tyrosine kinases (SFKs) (Howell et al. 1997; Arnaud et al. 2003; Bock and Herz 2003).”
Self-citationLack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice
Koldamova, R., Staufenbiel, M., & Lefterov, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504513200 · Cited by 350 · cited 3×
“When APP Tg mice are crossed onto an Abca1 background, this decreases apoE lipidation and increases amyloid deposition (Hirsch-Reinshagen et al. 2005; Koldamova et al. 2005a; Wahrle et al. 2005), whereas increasing ABCA1 increases apoE lipidation and decreases amyloid deposition (Wahrle et al.”
Holtzman, D. M., Pitas, R. E., Kilbridge, J., Nathan, B., Mahley, R. W., Bu, G., & Schwartz, A. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9480 · Cited by 349 · cited 1×
“Although there is some in vitro (Nathan et al. 1994; Holtzman et al. 1995) and in vivo (Masliah et al. 1995; Poirier 2003) data suggesting that apoE can play a role in neuronal sprouting after injury, whether apoE plays a major role in supporting synaptogenesis and maintenance of synaptic…”
BackgroundSelf-citationEvans, K. C., Berger, E. P., Cho, C. G., Weisgraber, K. H., & Lansbury, P. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.763 · Cited by 333
Deletion of Abca1 Increases Aβ Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease
Wahrle, S. E., Jiang, H., Parsadanian, M., Hartman, R. E., Bales, K. R., Paul, S. M., & Holtzman, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508780200 · Cited by 325 · cited 1×
“…APP Tg mice are crossed onto an Abca12/2 background, this decreases apoE lipidation and increases amyloid deposition (Hirsch-Reinshagen et al. 2005; Koldamova et al. 2005a; Wahrle et al. 2005), whereas increasing ABCA1 increases apoE lipidation and decreases amyloid deposition (Wahrle et al. 2008).”
BackgroundSelf-citationLoss of apolipoprotein E receptor LR11 in Alzheimer disease
Scherzer, C. R., Offe, K., Gearing, M., Rees, H. D., Fang, G., Heilman, C. J., Schaller, C., Bujo, H., Levey, A. I., & Lah, J. J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1200 · Cited by 316 · cited 1×
“A third apoE receptor that modulates APP trafficking and processing to Ab is sorLA/LR11 whose expression is significantly reduced in AD brains (Scherzer et al. 2004).”
Kim, J., Castellano, J. M., Jiang, H., Basak, J. M., Parsadanian, M., Pham, V., Mason, S. M., Paul, S. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.013 · Cited by 308 · cited 7×
“Strong evidence suggests a major mechanism by which apoE influences AD and cerebral amyloid angiopathy (CAA) is via its effects on Ab metabolism (Kim et al. 2009a; Castellano et al. 2011).”
BackgroundInfluentialSelf-citationReelin-mediated Signaling Locally Regulates Protein Kinase B/Akt and Glycogen Synthase Kinase 3β
Beffert, U., Morfini, G., Bock, H. H., Reyna, H., Brady, S. T., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209205200 · Cited by 306 · cited 4×
“…in the ligand, the receptors, or the adaptor protein, results in reduced phosphorylation of GSK3b on an inhibitory serine residue, which leads to disinhibition of the enzyme and hyperphosphorylation of tau (Hiesberger et al. 1999; Beffert et al. 2002; Brich et al. 2003; Ohkubo et al. 2003).”
BackgroundInfluentialSelf-citationSydow, A., Van der Jeugd, A., Zheng, F., Ahmed, T., Balschun, D., Petrova, O., Drexler, D., Zhou, L., Rune, G., Mandelkow, E., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5245-10.2011 · Cited by 302 · cited 1×
“Intriguingly, the tau-induced synaptic defects are prevented or reversed by reducing the tau levels (Roberson et al. 2011; Sydow et al. 2011).”
Reelin modulates NMDA receptor activity in cortical neurons
Chen, Y., Beffert, U., Ertunc, M., Tang, T.-S., Kavalali, E. T., Bezprozvanny, I., & Herz, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1951-05.2005 · Cited by 299 · cited 9×
“…al. 2004), n-cofilin-mediated actin reorganization (Chai et al. 2009; Frotscher 2010), and tyrosine phosphorylation of NMDA Cite this article as Cold Spring Harb Perspect Med 2012;2:a006312 7 w w w .p er sp ec ti ve si n m ed ic in e. o rg receptor subunits (Beffert et al. 2005; Chen et al. 2005).”
InfluentialSelf-citationFagan, A. M., Watson, M., Parsadanian, M., Bales, K. R., Paul, S. M., & Holtzman, D. M. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0483 · Cited by 290 · cited 2×
“E2) (Holtzman et al. 2000a; Fagan et al. 2002; Fryer et al. 2005b).”
BackgroundSelf-citationMouse disabled (mDab1): a src binding protein implicated in neuronal development
Howell, B. W., Gertler, F. B., & Cooper, J. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.121 · Cited by 287 · cited 2×
“2005) results in the progressive recruitment and transphosphorylation of Src family tyrosine kinases (SFKs) (Howell et al. 1997; Arnaud et al. 2003; Bock and Herz 2003).”
Nascent astrocyte particles differ from lipoproteins in CSF
LaDu, M. J., Gilligan, S. M., Lukens, J. R., Cabana, V. G., Reardon, C. A., Van Eldik, L. J., & Holtzman, D. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052070.x · Cited by 285 · cited 1×
“ApoE is also present in cerebrospinal fluid (CSF) at a concentration of 5 mg/ml, in spherical particles that are similar to glial-secreted HDL, except that they also contain a cholesteryl ester core (LaDu et al. 1998).”
Self-citationFyn Tyrosine Kinase Is a Critical Regulator of Disabled-1 during Brain Development
Arnaud, L., Ballif, B. A., Förster, E., & Cooper, J. A. (2003) · Current Biology · doi:10.1016/s0960-9822(02)01397-0 · Cited by 283 · cited 2×
“2005) results in the progressive recruitment and transphosphorylation of Src family tyrosine kinases (SFKs) (Howell et al. 1997; Arnaud et al. 2003; Bock and Herz 2003).”
Koldamova, R. P., Lefterov, I. M., Staufenbiel, M., Wolfe, D., Huang, S., Glorioso, J. C., Walter, M., Roth, M. G., & Lazo, J. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411420200 · Cited by 279 · cited 2×
“…APP Tg mice are crossed onto an Abca12/2 background, this decreases apoE lipidation and increases amyloid deposition (Hirsch-Reinshagen et al. 2005; Koldamova et al. 2005a; Wahrle et al. 2005), whereas increasing ABCA1 increases apoE lipidation and decreases amyloid deposition (Wahrle et al. 2008).”
BackgroundFryer, J. D., Simmons, K., Parsadanian, M., Bales, K. R., Paul, S. M., Sullivan, P. M., & Holtzman, D. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5170-04.2005 · Cited by 278 · cited 8×
“Second, deletion of the Lrp1 gene in mouse forebrain neurons reduces brain cholesterol levels (Liu et al. 2007), whereas cholesterol levels in Ldlr knockout mice are unchanged (Fryer et al. 2005a).”
BackgroundResultInfluentialSelf-citationTOKUDA, T., CALERO, M., MATSUBARA, E., VIDAL, R., KUMAR, A., PERMANNE, B., ZLOKOVIC, B., SMITH, J. D., LADU, M. J., ROSTAGNO, A., et al. (2000) · Biochemical Journal · doi:10.1042/bj3480359 · Cited by 272 · cited 1×
“Lipid-free and lipidated (physiological) forms of apoE can interact with Ab in vitro (Strittmatter et al. 1993b; LaDu et al. 1994; Sanan et al. 1994; Aleshkov et al. 1997; Yang et al. 1997; Tokuda et al. 2000).”
BackgroundUlery, P. G., Beers, J., Mikhailenko, I., Tanzi, R. E., Rebeck, G. W., Hyman, B. T., & Strickland, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7410 · Cited by 271 · cited 1×
“Because of the rapid endocytosis rate of LRP1 compared with that of APP (Cam et al. 2005), the consequence of APP and LRP1 interaction is accelerated APP endocytic trafficking and processing to Ab (Ulery et al. 2000; Zerbinatti et al. 2004; Cam et al. 2005; Zerbinatti et al. 2006).”
BackgroundDe Ferrari, G. V., Papassotiropoulos, A., Biechele, T., Wavrant De-Vrieze, F., Avila, M. E., Major, M. B., Myers, A., Sáez, K., Henríquez, J. P., Zhao, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603523104 · Cited by 270 · cited 1×
“LRP1 has been repeatedly, albeit weakly, associated with AD risk (Beffert et al. 1999; Vazquez-Higuera et al. 2009), and a coding polymorphism in the distantly related Wnt coreceptor LRP6 has also been implicated (De Ferrari et al. 2007).”
Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E
Castano, E. M., Prelli, F., Wisniewski, T., Golabek, A., Kumar, R. A., Soto, C., & Frangione, B. (1995) · Biochemical Journal · doi:10.1042/bj3060599 · Cited by 267 · cited 1×
“E2) (Ma et al. 1994; Wisniewski et al. 1994; Castano et al. 1995), whereas others show that apoE inhibits fibrillization (Evans et al. 1994; Wood et al. 1996).”
BackgroundThe Reelin signaling pathway promotes dendritic spine development in hippocampal neurons
Niu, S., Yabut, O., & D'Arcangelo, G. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1917-08.2008 · Cited by 266 · cited 4×
“…Brich et al. 2003; Ohkubo et al. 2003; Chai et al. 2009; Forster et al. 2010; Rust et al. 2010), dendritogenesis (Niu et al. 2004), spine formation (Niu et al. 2008), glutamate receptor function and synaptic plasticity (Zhuo et al. 2000; Weeber et al. 2002; Beffert et al. 2005; Chen et al. 2005;…”
InfluentialGSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila
Mudher, A., Shepherd, D., Newman, T. A., Mildren, P., Jukes, J. P., Squire, A., Mears, A., Berg, S., MacKay, D., Asuni, A. A., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001483 · Cited by 265 · cited 2×
“High levels of tau phosphorylation disrupt neuronal vesicle transport by compromising microtubule stability (Mudher et al. 2004), and consequently lead to variable degrees of neuronal dysfunction and premature death of signaling defective mutant mice (Sheldon et al. 1997; Trommsdorff et al. 1999;…”
BackgroundLoukinova, E., Ranganathan, S., Kuznetsov, S., Gorlatova, N., Migliorini, M. M., Loukinov, D., Ulery, P. G., Mikhailenko, I., Lawrence, D. A., & Strickland, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200427200 · Cited by 260 · cited 1×
“…their extracellular domains with other types of signaling proteins and modules, and thereby modulate their intrinsic activity (Boucher et al. 2002; Loukinova et al. 2002; Huang et al. 2003; Lillis et al. 2008; Zurhove et al. 2008), including that of the N-methyl-D-aspartate (NMDA) receptor (May…”
BackgroundRole of Tissue Plasminogen Activator Receptor LRP in Hippocampal Long-Term Potentiation
Zhuo, M., Holtzman, D. M., Li, Y., Osaka, H., DeMaro, J., Jacquin, M., & Bu, G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00542.2000 · Cited by 258 · cited 2×
“…2010; Rust et al. 2010), dendritogenesis (Niu et al. 2004), spine formation (Niu et al. 2008), glutamate receptor function and synaptic plasticity (Zhuo et al. 2000; Weeber et al. 2002; Beffert et al. 2005; Chen et al. 2005; D’Arcangelo 2005; Sinagra et al. 2005; Groc et al. 2007; Durakoglugil et…”
Self-citationRönicke, R., Mikhaylova, M., Rönicke, S., Meinhardt, J., Schröder, U. H., Fändrich, M., Reiser, G., Kreutz, M. R., & Reymann, K. G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.011 · Cited by 247
Michikawa, M., Fan, Q., Isobe, I., & Yanagisawa, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741008.x · Cited by 244 · cited 2×
“There is some evidence that apoE isoforms may differ in their function in regard to cholesterol transport and efflux (Michikawa et al. 2000; Gong et al. 2002; Rapp et al. 2006), although not all studies show this (Hirsch-Reinshagen et al. 2004).”
The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2
Stockinger, W., Brandes, C., Fasching, D., Hermann, M., Gotthardt, M., Herz, J., Schneider, W. J., & Nimpf, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004119200 · Cited by 239 · cited 2×
“2006b), but also serves to recruit a c-jun amino-terminal kinase (JNK) signaling complex to the cytoplasmic tail of Apoer2 (Gotthardt et al. 2000; Stockinger et al. 2000).”
Self-citationMay, P., Rohlmann, A., Bock, H. H., Zurhove, K., Marth, J. D., Schomburg, E. D., Noebels, J. L., Beffert, U., Sweatt, J. D., Weeber, E. J., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8872-8883.2004 · Cited by 236 · cited 5×
“…1996; Trommsdorff 6 Cite this article as Cold Spring Harb Perspect Med 2012;2:a006312 w w w .p er sp ec ti ve si n m ed ic in e. o rg et al. 1999; May et al. 2004; Boycott et al. 2005; Boycott et al. 2009), may occlude their participation in AD pathogenesis, which would manifest itself much…”
InfluentialSelf-citationHirsch-Reinshagen, V., Maia, L. F., Burgess, B. L., Blain, J.-F., Naus, K. E., McIsaac, S. A., Parkinson, P. F., Chan, J. Y., Tansley, G. H., Hayden, M. R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508781200 · Cited by 233 · cited 2×
“When APP Tg mice are crossed onto an Abca1 background, this decreases apoE lipidation and increases amyloid deposition (Hirsch-Reinshagen et al. 2005; Koldamova et al. 2005a; Wahrle et al. 2005), whereas increasing ABCA1 increases apoE lipidation and decreases amyloid deposition (Wahrle et al.”
Rebeck, G. W., Harr, S. D., Hyman, B. T., & Strickland, D. K. (1995) · Annals of Neurology · doi:10.1002/ana.410370212 · Cited by 232 · cited 1×
“The best-characterized Ab clearance receptor in the brain is LRP1, which along with several of its ligands are present in amyloid plaques (Rebeck et al. 1995).”
BackgroundSchaefer, E. J., Heaton, W. H., Wetzel, M. G., & Brewer, H. B. (1982) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.2.1.16 · Cited by 229 · cited 1×
“Genetic deficiency of either protein in humans or mice does not result in an obvious CNS phenotype (Schaefer et al. 1982; McLaughlin et al. 2000).”
Fagan, A. M., Bu, G., Sun, Y., Daugherty, A., & Holtzman, D. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.30121 · Cited by 226 · cited 2×
“…si n m ed ic in e. o rg particles secreted by astrocytes have higher affinity for LDLR than LRP1 (Fryer et al. 2005a), whereas recombinant apoE (Narita et al. 2002), apoE-enriched lipoprotein particles (Kowal et al. 1990), and CSF-isolated HDL particles (Fagan et al. 1996) bind more avidly to LRP1.”
Self-citationImpact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease
Tiraboschi, P., Hansen, L. A., Masliah, E., Alford, M., Thal, L. J., & Corey-Bloom, J. (2004) · Neurology · doi:10.1212/01.wnl.0000128091.92139.0f · Cited by 226 · cited 2×
“Although some studies reported conflicting findings (Benjamin et al. 1995; Heinonen et al. 1995), a large autopsy study strongly suggested that 14 dosage is associated with increased neuritic plaques in AD (Tiraboschi et al. 2004).”
Groc, L., Choquet, D., Stephenson, F. A., Verrier, D., Manzoni, O. J., & Chavis, P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1772-07.2007 · Cited by 225 · cited 3×
“Similarly, Reelin has been shown to regulate surface mobility and synaptic residency of NMDA receptor NR2B subunits (Groc et al. 2007).”
Learning, AMPA receptor mobility and synaptic plasticity depend on n‐cofilin‐mediated actin dynamics
Rust, M. B., Gurniak, C. B., Renner, M., Vara, H., Morando, L., Görlich, A., Sassoè‐Pognetto, M., Banchaabouchi, M. A., Giustetto, M., Triller, A., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.72 · Cited by 224 · cited 2×
“Reelin signaling also regulates dendritic spine morphology (Costa et al. 2001; Niu et al. 2008; Pujadas et al. 2010), which likely involves regulation of actin dynamics and the participation of n-cofilin (Chai et al. 2009; Rust et al. 2010).”
BackgroundBoycott, K. M., Flavelle, S., Bureau, A., Glass, H. C., Fujiwara, T. M., Wirrell, E., Davey, K., Chudley, A. E., Scott, J. N., McLeod, D. R., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/444400 · Cited by 221 · cited 1×
“…Cite this article as Cold Spring Harb Perspect Med 2012;2:a006312 w w w .p er sp ec ti ve si n m ed ic in e. o rg et al. 1999; May et al. 2004; Boycott et al. 2005; Boycott et al. 2009), may occlude their participation in AD pathogenesis, which would manifest itself much later in life.”
ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons In Vivo
Dumanis, S. B., Tesoriero, J. A., Babus, L. W., Nguyen, M. T., Trotter, J. H., Ladu, M. J., Weeber, E. J., Turner, R. S., Xu, B., Rebeck, G. W., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4026-09.2009 · Cited by 220 · cited 1×
“This mechanism is also consistent with the finding that ApoE4 reduces spine density and dendritic complexity in cortical neurons in vivo (Dumanis et al. 2009).”
Apolipoprotein E receptors: linking brain development and alzheimer's disease
Herz, J., & Beffert, U. (2000) · Nature Reviews Neuroscience · doi:10.1038/35036221 · Cited by 219 · cited 1×
“…al. 2000; Weeber et al. 2002; Beffert et al. 2005; Chen et al. 2005; D’Arcangelo 2005; Sinagra et al. 2005; Groc et al. 2007; Durakoglugil et al. 2009; Korwek et al. 2009; Chen et al. 2010), as well as learning and memory (reviewed in Herz and Beffert 2000; Herz and Chen 2006; Bu 2009; Herz 2009).”
Self-citationInteraction of reelin signaling and Lis1 in brain development
Assadi, A. H., Zhang, G., Beffert, U., McNeil, R. S., Renfro, A. L., Niu, S., Quattrocchi, C. C., Antalffy, B. A., Sheldon, M., Armstrong, D. D., et al. (2003) · Nature Genetics · doi:10.1038/ng1257 · Cited by 219 · cited 2×
“…neuronal survival (Beffert et al. 2006b) during aging involve signaling pathways that control microtubule and actin dynamics (Beffert et al. 2002; Assadi et al. 2003; Brich et al. 2003; Ohkubo et al. 2003; Chai et al. 2009; Forster et al. 2010; Rust et al. 2010), dendritogenesis (Niu et al.…”
Self-citationReelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation
Pujadas, L., Gruart, A., Bosch, C., Delgado, L., Teixeira, C. M., Rossi, D., de Lecea, L., Martínez, A., Delgado-García, J. M., & Soriano, E. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5284-09.2010 · Cited by 219 · cited 6×
“These findings explain the profound effect of Reelin on glutamatergic neurotransmission and synaptic plasticity ex corpore (Weeber et al. 2002; Beffert et al. 2005; Beffert et al. 2006b; Qiu et al. 2006; Campo et al. 2009) and in vivo (Pujadas et al. 2010) (E Weeber, pers. comm.).”
InfluentialGong, J.-S., Kobayashi, M., Hayashi, H., Zou, K., Sawamura, N., Fujita, S. C., Yanagisawa, K., & Michikawa, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203934200 · Cited by 214 · cited 2×
“There is some evidence that apoE isoforms may differ in their function in regard to cholesterol transport and efflux (Michikawa et al. 2000; Gong et al. 2002; Rapp et al. 2006), although not all studies show this (Hirsch-Reinshagen et al. 2004).”
Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis
McLaughlin, L., Zhu, G., Mistry, M., Ley-Ebert, C., Stuart, W. D., Florio, C. J., Groen, P. A., Witt, S. A., Kimball, T. R., Witte, D. P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9037 · Cited by 207 · cited 1×
“Genetic deficiency of either protein in humans or mice does not result in an obvious CNS phenotype (Schaefer et al. 1982; McLaughlin et al. 2000).”
BackgroundNarita, M., Holtzman, D. M., Schwartz, A. L., & Bu, G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051904.x · Cited by 204
Self-citationOligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism
Berman, D. E., Dall'Armi, C., Voronov, S. V., McIntire, L. B. J., Zhang, H., Moore, A. Z., Staniszewski, A., Arancio, O., Kim, T.-W., & Di Paolo, G. (2008) · Nature Neuroscience · doi:10.1038/nn.2100 · Cited by 199 · cited 1×
“…1998; Walsh et al. 2002; Lacor et al. 2004; Snyder et al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo et al. 2008; Shankar et al. 2008; Nygaard and Strittmatter 2009; Gimbel et al. 2010; Palop and Mucke 2010; Renner et al.…”
BackgroundCosta, E., Davis, J., Grayson, D. R., Guidotti, A., Pappas, G. D., & Pesold, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0436 · Cited by 195 · cited 4×
“…and observations point toward a role for Reelin and ApoE receptors in the formation of neuronal connections (Del Rio et al. 1997; Borrell et al. 2007) and the generation of dendritic complexity (Trommsdorff et al. 1999; Costa et al. 2001; Niu et al. 2004; Matsuki et al. 2008; Hoe et al. 2009).”
InfluentialReceptor Clustering Is Involved in Reelin Signaling
Strasser, V., Fasching, D., Hauser, C., Mayer, H., Bock, H. H., Hiesberger, T., Herz, J., Weeber, E. J., Sweatt, J. D., Pramatarova, A., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1378-1386.2004 · Cited by 193 · cited 2×
“1999), resulting in their clustering at the plasma membrane (Strasser et al. 2004).”
Self-citationBoucher, P., Liu, P., Gotthardt, M., Hiesberger, T., Anderson, R. G. W., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200428200 · Cited by 188 · cited 2×
“The receptors can also interact as coreceptors through their extracellular domains with other types of signaling proteins and modules, and thereby modulate their intrinsic activity (Boucher et al. 2002; Loukinova et al. 2002; Huang et al. 2003; Lillis et al. 2008; Zurhove et al. 2008), including that of the N-methyl-D…”
Self-citationChin, J., Massaro, C. M., Palop, J. J., Thwin, M. T., Yu, G.-Q., Bien-Ly, N., Bender, A., & Mucke, L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3758-06.2007 · Cited by 188 · cited 2×
“Moreover, Reelin expression levels are reduced in the brains of AD patients and in the entorhinal cortex of APP overexpressing mice (Chin et al. 2007), suggesting that Ab can reduce Reelin expression in a subset of entorhinal pyramidal neurons, thereby adding further support to a role of diminished Reelin signaling in…”
Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus
Qiu, S., Zhao, L. F., Korwek, K. M., & Weeber, E. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2561-06.2006 · Cited by 186 · cited 3×
“These findings explain the profound effect of Reelin on glutamatergic neurotransmission and synaptic plasticity ex corpore (Weeber et al. 2002; Beffert et al. 2005; Beffert et al. 2006b; Qiu et al. 2006; Campo et al. 2009) and in vivo (Pujadas et al. 2010) (E Weeber, pers. comm.).”
Sequence Diversity and Large-Scale Typing of SNPs in the Human Apolipoprotein E Gene
Nickerson, D. A., Taylor, S. L., Fullerton, S. M., Weiss, K. M., Clark, A. G., Stengård, J. H., Salomaa, V., Boerwinkle, E., & Sing, C. F. (2000) · Genome Research · doi:10.1101/gr.146900 · Cited by 184 · cited 1×
“The human apoE gene contains several singlenucleotide polymorphisms (SNPs) distributed across the gene (Nickerson et al. 2000).”
Burk, R. F., Hill, K. E., Olson, G. E., Weeber, E. J., Motley, A. K., Winfrey, V. P., & Austin, L. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1153-07.2007 · Cited by 181 · cited 1×
“Apoer2 also protects against neurodegeneration through another, mechanistically distinct mechanism, which involves its role in the uptake of essential selenoproteins into the brain (Burk et al. 2007).”
BackgroundDeMattos, R. B., Brendza, R. P., Heuser, J. E., Kierson, M., Cirrito, J. R., Fryer, J., Sullivan, P. M., Fagan, A. M., Han, X., & Holtzman, D. M. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00049-3 · Cited by 180 · cited 1×
“…of different size classes in plasma, in the CNS, it is the most abundantly produced apoprotein and is secreted by glial cells in nascent high-density lipoprotein (HDL)-like particles (Pitas et al. 1987; DeMattos et al. 2001) that are discoidal in shape and contain phospholipids and cholesterol.”
BackgroundSelf-citationSunderland, T., Mirza, N., Putnam, K. T., Linker, G., Bhupali, D., Durham, R., Soares, H., Kimmel, L., Friedman, D., Bergeson, J., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.021 · Cited by 179 · cited 2×
“Cognitively normal apoE4-positive middle-aged and elderly individuals are much more likely to have brain amyloid (Reiman et al. 2009; Morris et al. 2010) and low CSF Ab42 (Sunderland et al. 2004; Morris et al. 2010) than apoE4-negative individuals.”
BackgroundPietrzik, C. U., Yoon, I.-S., Jaeger, S., Busse, T., Weggen, S., & Koo, E. H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5451-03.2004 · Cited by 173 · cited 1×
“Two different phosphotyrosinebinding (PTB) domains within the adaptor protein FE65 bind to the NPxY motifs within APP and LRP1, thus bridging an interaction between these two membrane proteins intracellularly (Trommsdorff et al. 1998; Kinoshita et al. 2001; Pietrzik et al. 2004).”
Putting cholesterol in its place: apoE and reverse cholesterol transport
Mahley, R. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28632 · Cited by 171 · cited 1×
“Although the three common isoforms differ by only one or two amino acids at residues 112 or 158, these differences alter apoE structure and function (Mahley et al. 2006).”
Sadowski, M. J., Pankiewicz, J., Scholtzova, H., Mehta, P. D., Prelli, F., Quartermain, D., & Wisniewski, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604011103 · Cited by 167 · cited 1×
“In terms of apoE-dependent Ab aggregation, interrupting the apoE-Ab interaction may also have therapeutic potential (Sadowski et al. 2006).”
Backgroundγ-Secretase Limits the Inflammatory Response Through the Processing of LRP1
Zurhove, K., Nakajima, C., Herz, J., Bock, H. H., & May, P. (2008) · Science Signaling · doi:10.1126/scisignal.1164263 · Cited by 162 · cited 2×
“…and modules, and thereby modulate their intrinsic activity (Boucher et al. 2002; Loukinova et al. 2002; Huang et al. 2003; Lillis et al. 2008; Zurhove et al. 2008), including that of the N-methyl-D-aspartate (NMDA) receptor (May et al. 2004; Beffert et al. 2005; Hoe et al. 2006b).”
BackgroundSelf-citationCellular growth inhibition by IGFBP‐3 and TGF‐β 1 requires LRP‐1
Huang, S. S., Ling, T., Tseng, W.-F., Huang, Y.-H., Tang, F.-M., Leal, S. M., & Huang, J. S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0256com · Cited by 161 · cited 1×
“…with other types of signaling proteins and modules, and thereby modulate their intrinsic activity (Boucher et al. 2002; Loukinova et al. 2002; Huang et al. 2003; Lillis et al. 2008; Zurhove et al. 2008), including that of the N-methyl-D-aspartate (NMDA) receptor (May et al. 2004; Beffert et…”
BackgroundFryer, J. D., Taylor, J. W., DeMattos, R. B., Bales, K. R., Paul, S. M., Parsadanian, M., & Holtzman, D. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07889.2003 · Cited by 160 · cited 1×
“…mice were crossed with apoE2/2 mice, there was less Ab deposition and a virtual abolishment of true amyloid plaques, plaque-associated neuritic dystrophy, CAA, and CAA-associated microhemorrhage in the absence of apoE (Bales et al. 1997; Bales et al. 1999; Holtzman et al. 2000b; Fryer et al. 2003).”
BackgroundSelf-citationLRP2 in ependymal cells regulates BMP signaling in the adult neurogenic niche
Gajera, C. R., Emich, H., Lioubinski, O., Christ, A., Beckervordersandforth, R., Yoshikawa, K., Bachmann, S., Christensen, E., Götz, M., Kempermann, G., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.065912 · Cited by 160 · cited 2×
“…to AD development and progression may include roles in the control of inflammation (Lillis et al. 2008; Zurhove et al. 2008), cholesterol metabolism (reviewed in Herz et al. 2009), neurogenesis (Gajera et al. 2010), or the generation and trafficking of APP and Ab (reviewed in the third section).”
Role for Reelin in stabilizing cortical architecture
Frotscher, M. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.06.001 · Cited by 157 · cited 3×
“2004), n-cofilin-mediated actin reorganization (Chai et al. 2009; Frotscher 2010), and tyrosine phosphorylation of NMDA Apolipoprotein E and Apolipoprotein E Receptors”
Reelin signaling antagonizes β-amyloid at the synapse
Durakoglugil, M. S., Chen, Y., White, C. L., Kavalali, E. T., & Herz, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908176106 · Cited by 153 · cited 2×
“This hypothesis was tested by measuring the effect of different Ab preparations, including Ab-containing extracts from human AD brain, on hippocampal synaptic plasticity, NMDA receptor tyrosine phosphorylation, and activity in response to Reelin (Durakoglugil et al. 2009).”
BackgroundSelf-citationLipoprotein receptors – an evolutionarily ancient multifunctional receptor family
Dieckmann, M., Dietrich, M. F., & Herz, J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.129 · Cited by 147 · cited 1×
“(From Dieckmann et al. 2010; reprinted, with permission, from Walter de Gruyter GmbH # 2010.)”
Self-citationTerrand, J., Bruban, V., Zhou, L., Gong, W., El Asmar, Z., May, P., Zurhove, K., Haffner, P., Philippe, C., Woldt, E., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806538200 · Cited by 143 · cited 1×
“Loss of LRP1 also results in increased GSK3b activity, at least in fibroblasts and adipocytes, as a result of a loss of autocrine Wnt5a expression (Terrand et al. 2009).”
Self-citationAbnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice
Johnson, E. B., Hammer, R. E., & Herz, J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi381 · Cited by 141 · cited 2×
“The very nature of their essential functions during the development of the embryo in general (Herz et al. 1992; Johnson et al. 2005; Dietrich et al. 2010; Karner et al. 2010), and the brain, in particular (Willnow et al. 1996; Trommsdorff 6 Cite this article as Cold Spring Harb Perspect Med…”
Self-citationFryer, J. D., DeMattos, R. B., McCormick, L. M., O'Dell, M. A., Spinner, M. L., Bales, K. R., Paul, S. M., Sullivan, P. M., Parsadanian, M., Bu, G., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502143200 · Cited by 139 · cited 8×
“Second, deletion of the Lrp1 gene in mouse forebrain neurons reduces brain cholesterol levels (Liu et al. 2007), whereas cholesterol levels in Ldlr knockout mice are unchanged (Fryer et al. 2005a).”
BackgroundResultInfluentialSelf-citationAleshkov, S., Abraham, C. R., & Zannis, V. I. (1997) · Biochemistry · doi:10.1021/bi9626362 · Cited by 138 · cited 1×
“Lipid-free and lipidated (physiological) forms of apoE can interact with Ab in vitro (Strittmatter et al. 1993b; LaDu et al. 1994; Sanan et al. 1994; Aleshkov et al. 1997; Yang et al. 1997; Tokuda et al. 2000).”
BackgroundGrehan, S., Tse, E., & Taylor, J. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00812.2001 · Cited by 138 · cited 1×
“2) (Pitas et al. 1987; Grehan et al. 2001).”
Seeding of Aβ Fibril Formation Is Inhibited by All Three Isotypes of Apolipoprotein E
Wood, S. J., Chan, W., & Wetzel, R. B. (1996) · Biochemistry · doi:10.1021/bi961074j · Cited by 136 · cited 1×
“E2) (Ma et al. 1994; Wisniewski et al. 1994; Castano et al. 1995), whereas others show that apoE inhibits fibrillization (Evans et al. 1994; Wood et al. 1996).”
BackgroundOhkubo, N., Lee, Y., Morishima, A., Terashima, T., Kikkawa, S., Tohyama, M., Sakanaka, M., Tanaka, J., Maeda, N., Vitek, M. P., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0434fje · Cited by 134 · cited 2×
“…in the ligand, the receptors, or the adaptor protein, results in reduced phosphorylation of GSK3b on an inhibitory serine residue, which leads to disinhibition of the enzyme and hyperphosphorylation of tau (Hiesberger et al. 1999; Beffert et al. 2002; Brich et al. 2003; Ohkubo et al. 2003).”
BackgroundZerbinatti, C. V., Wozniak, D. F., Cirrito, J., Cam, J. A., Osaka, H., Bales, K. R., Zhuo, M., Paul, S. M., Holtzman, D. M., & Bu, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305803101 · Cited by 133 · cited 1×
“Because of the rapid endocytosis rate of LRP1 compared with that of APP (Cam et al. 2005), the consequence of APP and LRP1 interaction is accelerated APP endocytic trafficking and processing to Ab (Ulery et al. 2000; Zerbinatti et al. 2004; Cam et al. 2005; Zerbinatti et al. 2006).”
BackgroundSelf-citationThe Effects of Amyloid Precursor Protein on Postsynaptic Composition and Activity
Hoe, H., Fu, Z., Makarova, A., Lee, J.-Y., Lu, C., Feng, L., Pajoohesh‐Ganji, A., Matsuoka, Y., Hyman, B. T., Ehlers, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900141200 · Cited by 133 · cited 4×
“…and observations point toward a role for Reelin and ApoE receptors in the formation of neuronal connections (Del Rio et al. 1997; Borrell et al. 2007) and the generation of dendritic complexity (Trommsdorff et al. 1999; Costa et al. 2001; Niu et al. 2004; Matsuki et al. 2008; Hoe et al. 2009).”
InfluentialKocherhans, S., Madhusudan, A., Doehner, J., Breu, K. S., Nitsch, R. M., Fritschy, J.-M., & Knuesel, I. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0418-10.2010 · Cited by 132 · cited 2×
“3), thus providing a novel mechanism by which accelerated spine loss, increased tau phosphorylation (Kocherhans et al. 2010), loss of network homeostasis (Palop et al. 2007; Palop and Mucke 2010), and earlier disease onset through loss of neuroprotective compensatory bandwidth (Korwek et al. 2009)…”
BackgroundEmerging topics in Reelin function
Förster, E., Bock, H. H., Herz, J., Chai, X., Frotscher, M., & Zhao, S. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07222.x · Cited by 130 · cited 2×
“…that control microtubule and actin dynamics (Beffert et al. 2002; Assadi et al. 2003; Brich et al. 2003; Ohkubo et al. 2003; Chai et al. 2009; Forster et al. 2010; Rust et al. 2010), dendritogenesis (Niu et al. 2004), spine formation (Niu et al. 2008), glutamate receptor function and…”
Self-citationRapp, A., Gmeiner, B., & Hüttinger, M. (2006) · Biochimie · doi:10.1016/j.biochi.2005.10.007 · Cited by 130 · cited 3×
“There is some evidence that apoE isoforms may differ in their function in regard to cholesterol transport and efflux (Michikawa et al. 2000; Gong et al. 2002; Rapp et al. 2006), although not all studies show this (Hirsch-Reinshagen et al. 2004).”
Chameau, P. J. P., Inta, D., Vitalis, T., Monyer, H., Wadman, W. J., & van Hooft, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810764106 · Cited by 130 · cited 7×
“In addition to effects on the apoE/Ab pathway, apoE receptors such as Apoer2 and Vldlr play important roles in synaptic plasticity, tau phosphorylation, and neuroprotection.”
InfluentialZerbinatti, C. V., Wahrle, S. E., Kim, H., Cam, J. A., Bales, K., Paul, S. M., Holtzman, D. M., & Bu, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604436200 · Cited by 129 · cited 2×
“Similarly, conditional deletion of the Lrp1 gene in mouse forebrain neurons increases apoE levels (Liu et al. 2007) and overexpression of a functional LRP1 minireceptor in mouse brain decreases brain apoE levels (Zerbinatti et al. 2006).”
BackgroundSelf-citationSinagra, M., Verrier, D., Frankova, D., Korwek, K. M., Blahos, J., Weeber, E. J., Manzoni, O. J., & Chavis, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1757-05.2005 · Cited by 128 · cited 4×
“2008), glutamate receptor function and synaptic plasticity (Zhuo et al. 2000; Weeber et al. 2002; Beffert et al. 2005; Chen et al. 2005; D’Arcangelo 2005; Sinagra et al. 2005; Groc et al. 2007; Durakoglugil et al. 2009; Korwek et al. 2009; Chen et al. 2010), as well as learning and memory (reviewed in Herz and Beffert…”
InfluentialFarrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 1×
“Importantly, the 12 allele of apoE is associated with a lower risk for AD (Corder et al. 1994; Farrer et al. 1997) with an odds ratio of 12 versus 13 of 0.62 as of June 2011 (www.alzgene.org).”
BackgroundInfluentialHoe, H.-S., Wessner, D., Beffert, U., Becker, A. G., Matsuoka, Y., & Rebeck, G. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9259-9268.2005 · Cited by 122 · cited 1×
“In the presence of Fspondin, a common ligand that bridges APP and Apoer2 extracellular interaction, the slow endocytosis rate of Apoer2 inhibits APP endocytic trafficking and reduces Ab production (Hoe et al. 2005).”
Beffert, U., Durudas, A., Weeber, E. J., Stolt, P. C., Giehl, K. M., Sweatt, J. D., Hammer, R. E., & Herz, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4566-05.2006 · Cited by 121 · cited 7×
“Recent evidence shows that ApoE receptors, specifically Apoer2 and LRP1, directly protect against the loss of neurons and dendrites in vivo (Beffert et al. 2006b).”
BackgroundInfluentialSelf-citationBehavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse
Anderson, R., Barnes, J. C., Bliss, T. V. P., Cain, D. P., Cambon, K., Davies, H. A., Errington, M. L., Fellows, L. A., Gray, R. A., Hoh, T., et al. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00598-8 · Cited by 119 · cited 1×
“For example, several studies have shown that the brain of apoE knockout mice, for the most part, appears normal in the absence of injury (Anderson et al. 1998; Fagan et al. 1998).”
BackgroundFagan, A. M., Murphy, B. A., Patel, S. N., Kilbridge, J. F., Mobley, W. C., Bu, G., & Holtzman, D. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6818 · Cited by 116 · cited 1×
“For example, several studies have shown that the brain of apoE knockout mice, for the most part, appears normal in the absence of injury (Anderson et al. 1998; Fagan et al. 1998).”
BackgroundSelf-citationApolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease
Poirier, J. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00007-8 · Cited by 116 · cited 2×
“1995) and in vivo (Masliah et al. 1995; Poirier 2003) data suggesting that apoE can play a role in neuronal sprouting after injury, whether apoE plays a major role in supporting synaptogenesis and maintenance of synaptic connections in vivo in the uninjured brain has not yet been proven.”
Kinoshita, A., Whelan, C. M., Smith, C. J., Mikhailenko, I., Rebeck, G. W., Strickland, D. K., & Hyman, B. T. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08354.2001 · Cited by 113 · cited 1×
“Two different phosphotyrosinebinding (PTB) domains within the adaptor protein FE65 bind to the NPxY motifs within APP and LRP1, thus bridging an interaction between these two membrane proteins intracellularly (Trommsdorff et al. 1998; Kinoshita et al. 2001; Pietrzik et al. 2004).”
BackgroundYang, D., Smith, J. D., Zhou, Z., Gandy, S. E., & Martins, R. N. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020721.x · Cited by 111
Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice
Cao, D., Fukuchi, K.-I., Wan, H., Kim, H., & Li, L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.011 · Cited by 106 · cited 1×
“One study showed that LDLR deficiency was associated with increased amyloid deposition in Tg2576 APP-transgenic mice (Cao et al. 2006).”
Apolipoprotein E Receptor 2 Interactions with the N-Methyl-D-aspartate Receptor
Hoe, H., Pocivavsek, A., Chakraborty, G., Fu, Z., Vicini, S., Ehlers, M., & Rebeck, G. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509380200 · Cited by 104 · cited 6×
“insert, which functionally couples Apoer2 to NMDA receptors, presumably through a PSD95-mediated interaction (Beffert et al. 2005; Hoe et al. 2006b), but also serves to recruit a c-jun amino-terminal kinase (JNK) signaling complex to the cytoplasmic tail of Apoer2 (Gotthardt et al.”
InfluentialAltered hippocampus synaptic function in selenoprotein P deficient mice
Peters, M. M., Hill, K. E., Burk, R. F., & Weeber, E. J. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-12 · Cited by 104 · cited 1×
“Selenoprotein 1 (Sepp1)-deficient animals show a pronounced LTP defect owing to selenium deficiency in the CNS when fed a selenium-reduced diet (Peters et al. 2006).”
Han, X. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04708.x · Cited by 101 · cited 3×
“14 Cite this article as Cold Spring Harb Perspect Med 2012;2:a006312 w w w .p er sp ec ti ve si n m ed ic in e. o rg by an apoE- and LRP1-dependent mechanism (Han 2007).”
InfluentialReelin secreted by GABAergic neurons regulates glutamate receptor homeostasis
Campo, C. G., Sinagra, M., Verrier, D., Manzoni, O. J., & Chavis, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005505 · Cited by 100 · cited 4×
“2005) and for the maintenance of normal NR2A/B ratios (Campo et al. 2009).”
InfluentialGenetic Modulation of Tau Phosphorylation in the Mouse
Brich, J., Shie, F., Howell, B. W., Li, R., Tus, K., Wakeland, E. K., Jin, L., Mumby, M. C., Churchill, G. A., Herz, J., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00187.2003 · Cited by 96 · cited 7×
“…(Beffert et al. 2006b) during aging involve signaling pathways that control microtubule and actin dynamics (Beffert et al. 2002; Assadi et al. 2003; Brich et al. 2003; Ohkubo et al. 2003; Chai et al. 2009; Forster et al. 2010; Rust et al. 2010), dendritogenesis (Niu et al. 2004), spine formation…”
InfluentialSelf-citationSorci‐Thomas, M. G., Prack, M. M., Dashti, N., Johnson, F., Rudel, L. L., & Williams, D. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60697-0 · Cited by 95
Irizarry, M. C., Cheung, B. S., Rebeck, G. W., Paul, S. M., Bales, K. R., & Hyman, B. T. (2000) · Acta Neuropathologica · doi:10.1007/s004010000263 · Cited by 93 · cited 1×
“In addition, the anatomical pattern of Ab deposition differs in the absence of apoE (Holtzman et al. 2000a; Irizarry et al. 2000).”
BackgroundReduction of Crk and CrkL expression blocks reelin-induced dendritogenesis
Matsuki, T., Pramatarova, A., & Howell, B. W. (2008) · Journal of Cell Science · doi:10.1242/jcs.027334 · Cited by 92 · cited 2×
“…and observations point toward a role for Reelin and ApoE receptors in the formation of neuronal connections (Del Rio et al. 1997; Borrell et al. 2007) and the generation of dendritic complexity (Trommsdorff et al. 1999; Costa et al. 2001; Niu et al. 2004; Matsuki et al. 2008; Hoe et al. 2009).”
Van Uden, E., Mallory, M., Veinbergs, I., Alford, M., Rockenstein, E., & Masliah, E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09298.2002 · Cited by 91 · cited 1×
“The important function of LRP1 in brain Ab clearance was shown in amyloid mouse model with decreased LRP1 expression owing to a deletion of their chaperone RAP (Van Uden et al. 2002).”
BackgroundChiu-Ugalde, J., Theilig, F., Behrends, T., Drebes, J., Sieland, C., Subbarayal, P., Köhrle, J., Hammes, A., Schomburg, L., & Schweizer, U. (2010) · Biochemical Journal · doi:10.1042/bj20100779 · Cited by 91 · cited 1×
“LRP2 also mediates transport of this essential micronutrient (Chiu-Ugalde et al. 2010).”
Cam, J. A., Zerbinatti, C. V., Knisely, J. M., Hecimovic, S., Li, Y., & Bu, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313893200 · Cited by 89 · cited 1×
“LRP1B, which shares high sequence homology with LRP1 but has a significantly slower rate of endocytosis retains APP at the cell surface and reduces its processing to Ab (Cam et al. 2004).”
BackgroundSelf-citationApoE isoform-dependent changes in hippocampal synaptic function
Korwek, K. M., Trotter, J. H., LaDu, M. J., Sullivan, P. M., & Weeber, E. J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-21 · Cited by 89 · cited 4×
“2007; Palop and Mucke 2010), and earlier disease onset through loss of neuroprotective compensatory bandwidth (Korwek et al. 2009) can be readily explained.”
InfluentialExpanding functions of lipoprotein receptors
Herz, J., Chen, Y., Masiulis, I., & Zhou, L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800077-jlr200 · Cited by 87
Self-citationIto, S., Ohtsuki, S., Kamiie, J., Nezu, Y., & Terasaki, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04938.x · Cited by 85 · cited 1×
“E2) (Bell et al. 2007; Ito et al. 2007; Deane et al. 2008).”
ApoE receptor 2 controls neuronal survival in the adult brain
Beffert, U., Nematollah Farsian, F., Masiulis, I., Hammer, R. E., Yoon, S. O., Giehl, K. M., & Herz, J. (2006) · Current Biology · doi:10.1016/j.cub.2006.10.029 · Cited by 84 · cited 11×
“However, the synaptic defects of Apoer2 knockin mutants (Beffert et al. 2005; Beffert et al. 2006a; Beffert et al. 2006b) are not caused by selenium depletion, but by the loss of NMDA and AMPA receptor regulation (Masiulis et al.”
InfluentialSelf-citationNygaard, H. B., & Strittmatter, S. M. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.223 · Cited by 83 · cited 1×
“…al. 2005; Lesne et al. 2006; Townsend et al. 2006; Haass and Selkoe 2007; Shankar et al. 2007; Berman et al. 2008; Puzzo et al. 2008; Shankar et al. 2008; Nygaard and Strittmatter 2009; Gimbel et al. 2010; Palop and Mucke 2010; Renner et al. 2010; Ronicke et al. 2010) (see Mucke and Selkoe 2011).”
BackgroundApolipoprotein E receptors in the nervous system
Herz, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832d3a10 · Cited by 81 · cited 2×
“…al. 2000; Weeber et al. 2002; Beffert et al. 2005; Chen et al. 2005; D’Arcangelo 2005; Sinagra et al. 2005; Groc et al. 2007; Durakoglugil et al. 2009; Korwek et al. 2009; Chen et al. 2010), as well as learning and memory (reviewed in Herz and Beffert 2000; Herz and Chen 2006; Bu 2009; Herz 2009).”
Self-citationCam, J. A., Zerbinatti, C. V., Li, Y., & Bu, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500613200 · Cited by 76 · cited 1×
“Because of the rapid endocytosis rate of LRP1 compared with that of APP (Cam et al. 2005), the consequence of APP and LRP1 interaction is accelerated APP endocytic trafficking and processing to Ab (Ulery et al. 2000; Zerbinatti et al. 2004; Cam et al. 2005; Zerbinatti et al. 2006).”
BackgroundSelf-citation
Research works printed but not linked: 1
- Sanan DA, Weisgraber KH, Russel SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewksi T, Frangione B, Roses B, et al. 1994. Apolipoprotein E associates with b amyloid peptide of Alzheimer's disease to form novel monofibrils. J Clin Invest 94: 860 -869.
Cited by
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
“Those who inherit one copy of the 34 form have a three-fold higher risk of developing Alzheimer’s than those without the 34 form, while those who inherit two copies of the 34 form have an 8- to 12-fold higher risk [40,42,43].”
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
Metadata
- Authors
- Holtzman, D. M., Herz, J., & Bu, G.
- Affiliations
- Washington University in St. Louis (US)
- The University of Texas at Dallas (US)
- Mayo Clinic in Florida (US)
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-01-10
- Volume
- 2
- Issue
- 3
- Pages
- a006312-a006312
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC3282491
- OpenAlex
- W2143955562
- Cited by
- 782
- References
- 227
- Citations by year
- 2026: 39 · 2025: 45 · 2024: 39 · 2023: 51 · 2022: 76 · 2021: 79 · 2020: 67 · 2019: 66 · 2018: 51 · 2017: 51 · 2016: 60 · 2015: 42 · 2014: 59 · 2013: 41 · 2012: 14
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- National Institute on Aging (P01AG030128, R01AG027924, R01AG031784, R01AG035355)
- National Heart, Lung, and Blood Institute (R37HL063762)
- National Institute of Neurological Disorders and Stroke (R37NS034467, P01NS074969)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- apolipoprotein E, APOE isoforms, Alzheimer's disease, APOE ε4, APOE2, apoE receptors, low-density lipoprotein receptor family, ApoER2, VLDLR, LRP1, amyloid-beta, amyloid-beta aggregation, amyloid-beta clearance, lipid modification, synaptic plasticity, neuroinflammation, lipid transport, genetic risk factors, treatment options
- MeSH terms
- Alzheimer Disease, Animals, Apolipoproteins E, Brain, Carrier Proteins, Humans, Neuronal Plasticity, Phosphorylation, Amyloid beta-Peptides, Polymorphism, Single Nucleotide, Protein Transport, Low Density Lipoprotein Receptor-Related Protein-1, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.